Guillain-Barré Syndrome after COVID-19 accompanied byDysautonomia

dc.contributor.author	Tecellioglu, Mehmet
dc.contributor.author	Özcan, Cemal
dc.date.accessioned	2022-12-06T07:31:35Z
dc.date.available	2022-12-06T07:31:35Z
dc.date.issued	2021
dc.identifier.citation	TECELLİOĞLU M, ÖZCAN C (2021). Guillain-Barré Syndrome after COVID-19 accompanied byDysautonomia. Annals of Medical Research, 28(7), 1426 - 1429. 10.5455/annalsmedres.2021.03.265	en_US
dc.identifier.uri	https://search.trdizin.gov.tr/yayin/detay/458446/guillain-barre-syndrome-after-covid-19-accompanied-bydysautonomia
dc.identifier.uri	http://hdl.handle.net/11616/85602
dc.description.abstract	The COVID-19 pandemic that emerged in Wuhan, Hubei Province, China in December 2019 is ongoing. COVID-19 may also cause neurological symptoms with central or peripheral nervous system or skeletal muscle involvement. Guillain–Barré syndrome (GBS) is an autoimmune disorder of the peripheral nervous system that is usually triggered by bacterial or viral infections. Autonomic nerve involvement can be seen in GBS. Case reports suggest that GBS is linked to COVID-19 infection. Here, we present a case of GBS occurring after COVID-19, accompanied by dysautonomia.	en_US
dc.language.iso	eng	en_US
dc.rights	info:eu-repo/semantics/openAccess	en_US
dc.title	Guillain-Barré Syndrome after COVID-19 accompanied byDysautonomia	en_US
dc.type	article	en_US
dc.relation.ispartof	Annals of Medical Research	en_US
dc.department	İnönü Üniversitesi	en_US